Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Meters and Test Strips on the Express Scripts Commercial National Preferred Formulary Providing accurate and ...

FT. LAUDERDALE, Fla., December 02, 2025--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it’s TRUE METRIX ® Self-Monitoring Blood Glucose Systems are preferred for commercial patients on ...

Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation IMULDOSA, a biosimilar to STELARA® ...

Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation RALEIGH, N.C., Dec. 1, 2025 /PRNewswire/ -- ...

Screenshot by Emerald/Commercial Integrator. The Almo E4 Experience is, of course, a four-yearly regional event that brings together a product-packed exhibit floor, CTS RU-accredited education and ...

A reputable loan broker will drive the call with questions about your business and funding needs. You should come prepared with your business info and questions of your own. Many, or all, of the ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Rocket Lab wants NASA to open up the Mars Sample Return program to commercial competition, arguing it can carry out the mission faster and cheaper than the agency's alternatives. Credit: Rocket Lab ...

Returning Mars samples, collected by NASA’s Perseverance rover, is among the agency's highest science goals. Credit: NASA/JPL-Caltech/MSSS NASA plans to assess either using a beefed-up skycrane ...

The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly expands access to millions of commercially insured patients, improving availability of life-saving allergy ...

Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...